Literature DB >> 11374606

Mathematical modeling of carbon monoxide exposures from anesthetic breakdown: effect of subject size, hematocrit, fraction of inspired oxygen, and quantity of carbon monoxide.

H J Woehlck1, D Mei, M B Dunning, F Ruiz.   

Abstract

BACKGROUND: Carbon monoxide (CO) is produced by reaction of isoflurane, enflurane, and desflurane in desiccated carbon dioxide absorbents. The inspiratory CO concentration depends on the dryness and identity of the absorbent and anesthetic. The adaptation of existing mathematical models to a rebreathing circuit allows identification of patient factors that predispose to more severe exposures, as identified by carboxyhemoglobin concentration.
METHODS: From our companion study, the authors used quantitative in vitro CO production data for 60 min at 7.5% desflurane or 1.5% isoflurane at 1 l/min fresh gas flow. The carboxyhemoglobin concentration was calculated by iteratively solving the Coburn Forster Kane equation modified for a rebreathing system that incorporates the removal of CO by patient absorption. Demonstrating good fit of predicted carboxyhemoglobin concentrations to published data from animal and human exposures validated the model. Carboxyhemoglobin concentrations were predicted for exposures of various severity, patients of different sizes, hematocrit, and fraction of inspired oxygen.
RESULTS: The calculated carboxyhemoglobin concentrations closely predicted the experimental results of other investigators, thereby validating the model. These equations indicate the severity of CO poisoning is inversely related to the hemoglobin quantity of a subject. Fraction of inspired oxygen had the greatest effect in patients of small size with low hematocrit values, where equilibrium and not the rate of uptake determined carboxyhemoglobin concentrations.
CONCLUSION: This model predicts that patients with low hemoglobin quantities will have more severe CO exposures based on the attainment of a higher carboxyhemoglobin concentration. This includes patients of small size (pediatric population) and patients with anemia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11374606     DOI: 10.1097/00000542-200103000-00016

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  6 in total

Review 1.  Anesthesia-Related Carbon Monoxide Exposure: Toxicity and Potential Therapy.

Authors:  Richard J Levy
Journal:  Anesth Analg       Date:  2016-09       Impact factor: 5.108

2.  Monitoring of isoflurane and desflurane breakdown: interfering gases and infrared detection.

Authors:  H Woehlck; M B Dunning; K Nithipatikom
Journal:  J Clin Monit Comput       Date:  2000       Impact factor: 2.502

Review 3.  "CO in a pill": Towards oral delivery of carbon monoxide for therapeutic applications.

Authors:  Xiaoxiao Yang; Wen Lu; Minjia Wang; Chalet Tan; Binghe Wang
Journal:  J Control Release       Date:  2021-09-02       Impact factor: 11.467

Review 4.  Carbon monoxide and anesthesia-induced neurotoxicity.

Authors:  Richard J Levy
Journal:  Neurotoxicol Teratol       Date:  2016-09-09       Impact factor: 3.763

5.  Carbon monoxide production from five volatile anesthetics in dry sodalime in a patient model: halothane and sevoflurane do produce carbon monoxide; temperature is a poor predictor of carbon monoxide production.

Authors:  Christiaan Keijzer; Roberto Sgm Perez; Jaap J De Lange
Journal:  BMC Anesthesiol       Date:  2005-06-02       Impact factor: 2.217

Review 6.  Factors Contributing to CO Uptake and Elimination in the Body: A Critical Review.

Authors:  Ke-Ting Pan; Giovanni S Leonardi; Ben Croxford
Journal:  Int J Environ Res Public Health       Date:  2020-01-14       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.